Stock Track | JOINN Laboratories Soars 14.95% in Morning Trading After Annual Net Profit Triples on Biological Asset Gains

Stock Track03-31

JOINN Laboratories' stock soared 14.95% in morning trading following the release of its annual financial results.

The company reported that its net profit attributable to shareholders for 2025 reached RMB 298 million, marking a significant increase of 302.08% compared to the previous year. This substantial growth was primarily driven by gains from changes in the fair value of its biological assets, which amounted to RMB 476 million during the period.

JOINN Laboratories' biological assets consist primarily of non-human primate models used for non-clinical project evaluations, commonly referred to as laboratory monkeys. Despite a 17.87% year-on-year decrease in revenue to RMB 1.658 billion, the strong profit performance and an order backlog of approximately RMB 2.6 billion contributed to positive investor sentiment.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1142907013?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-31 09:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1142907013","market":"sg","top_or_hot":-1,"title":"Stock Track | JOINN Laboratories Soars 14.95% in Morning Trading After Annual Net Profit Triples on Biological Asset Gains","media":"Stock Track","content":"<p>JOINN Laboratories' stock soared 14.95% in morning trading following the release of its annual financial results.</p><p>The company reported that its net profit attributable to shareholders for 2025 reached RMB 298 million, marking a significant increase of 302.08% compared to the previous year. This substantial growth was primarily driven by gains from changes in the fair value of its biological assets, which amounted to RMB 476 million during the period.</p><p>JOINN Laboratories' biological assets consist primarily of non-human primate models used for non-clinical project evaluations, commonly referred to as laboratory monkeys. Despite a 17.87% year-on-year decrease in revenue to RMB 1.658 billion, the strong profit performance and an order backlog of approximately RMB 2.6 billion contributed to positive investor sentiment.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | JOINN Laboratories Soars 14.95% in Morning Trading After Annual Net Profit Triples on Biological Asset Gains</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | JOINN Laboratories Soars 14.95% in Morning Trading After Annual Net Profit Triples on Biological Asset Gains\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-03-31 09:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>JOINN Laboratories' stock soared 14.95% in morning trading following the release of its annual financial results.</p><p>The company reported that its net profit attributable to shareholders for 2025 reached RMB 298 million, marking a significant increase of 302.08% compared to the previous year. This substantial growth was primarily driven by gains from changes in the fair value of its biological assets, which amounted to RMB 476 million during the period.</p><p>JOINN Laboratories' biological assets consist primarily of non-human primate models used for non-clinical project evaluations, commonly referred to as laboratory monkeys. Despite a 17.87% year-on-year decrease in revenue to RMB 1.658 billion, the strong profit performance and an order backlog of approximately RMB 2.6 billion contributed to positive investor sentiment.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06127","symbol_name":"昭衍新药","start_time":0,"source_url":"","article_id":"1142907013","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1142907013","pubTimestamp":1774922196,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"JOINN Laboratories' stock soared 14.95% in morning trading following the release of its annual financial results.The company reported that its net profit attributable to shareholders for 2025 reached...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06127":"昭衍新药"},"translate_title":"个股赛道|生物资产收益年净利增三倍后，乔因实验室早盘大涨14.95%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06127":1},"content_text":"JOINN Laboratories' stock soared 14.95% in morning trading following the release of its annual financial results.The company reported that its net profit attributable to shareholders for 2025 reached RMB 298 million, marking a significant increase of 302.08% compared to the previous year. This substantial growth was primarily driven by gains from changes in the fair value of its biological assets, which amounted to RMB 476 million during the period.JOINN Laboratories' biological assets consist primarily of non-human primate models used for non-clinical project evaluations, commonly referred to as laboratory monkeys. Despite a 17.87% year-on-year decrease in revenue to RMB 1.658 billion, the strong profit performance and an order backlog of approximately RMB 2.6 billion contributed to positive investor sentiment.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1142907013","isCrawlerRequest":true}